BioSpace News Archive

Business

Dynatronics Announces 57% Increase in Top Line Sales for Fiscal 2018 First Quarter

Net sales for the quarter increased 56.8 percent to $12.8M, compared to $8.2M in the same period of the prior year.

November 14, 2017
·
7 min read
BioCapital

Epidarex Capital Portfolio Company Apellis Pharmaceuticals Completes IPO

Epidarex and its predecessor fund, MASA Life Science Ventures, were among the company’s earliest backers, funding the development of the company’s core technology shortly after its spin-out from the University of Pennsylvania.

November 14, 2017
·
2 min read
Business

Bionik Laboratories Reports Second Quarter Fiscal Year 2018 Financial Results

Bionik Laboratories today announced its second quarter fiscal year 2018 financial results for the three months ended September 30, 2017.

November 14, 2017
·
19 min read
Business

Cardiome Reports Third Quarter 2017 Financial Results

Cardiome today reported financial results for the third quarter ended September 30, 2017 and commented on recent accomplishments and plans.

November 14, 2017
·
27 min read
Business

ReShape Lifesciences Announces Third Quarter 2017 Financial Results

ReShape Lifesciences today reported financial results for the three months ended September 30, 2017.

November 14, 2017
·
13 min read
Valeant Announces Pricing of Private Offering of Add-on Secured Notes

Valeant announced today that it has priced its previously announced offering of $750,000,000 aggregate principal amount of its 5.500% senior secured notes due 2025.

November 14, 2017
·
4 min read
BioCapital

QIAGEN’s GeneReader NGS System Delivers Accuracy and Ease of Use for Clinical Research in Oncology

The studies are being presented this week at the AMP 2017 Annual Meeting in Salt Lake City, Utah, where QIAGEN also will demonstrate the GeneReader and other Sample to Insight solutions.

November 14, 2017
·
1 min read
Drug Development

Acceleron Announces Preclinical Results in Pulmonary Arterial Hypertension at the American Heart Association 2017 Scientific Sessions

The company expects to initiate a Phase 2 trial in 1H 2018.

November 14, 2017
·
5 min read
Business

Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights

Cash of $182.4 million as of September 30, 2017.

November 14, 2017
·
13 min read
Business

GTx Provides Corporate Update and Reports Third Quarter 2017 Financial Results

During the quarter, GTx raised net proceeds of $45.6 million in a private placement of its common stock and warrants to purchase its common stock.

November 14, 2017
·
12 min read